Intravenous Continuous Infusion of Dexamethasone Plus Tramadol Combined With Standard Morphine Patient-Controlled Analgesia After Total Abdominal Hysterectomy
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Visual analog scale (VAS) of pain
研究概览
简要总结
Dexamethasone has been recognized as an antiemetic agent after surgeries, and the combination of dexamethasone and tramadol remained stable in solution up to 5 days. In addition, i.v. basal infusion of tramadol is a certified technique in postoperative pain management. We purposed that combined administration of dexamethasone and tramadol adjunct to i.v. morphine is an effective way in treating postoperative pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 19 Years 至 64 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •ASA physical status I-II
- •Uterus myoma
排除标准
- •Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records.
- •Participants younger than 18yr,older than 65yr or pregnancy was eliminated.
- •Due to the significant changes in vital signs might affect cognition of pain and that of sensation, over 20% variation of these records from the baselines or below 92% of SpO2 under 20-40% nasal tube oxygen at any time should be excluded from the study.
- •Those who were not willing to or could not finish the whole study at any time.
- •Any patient who exhibited a combative or incoherent state of PCA analgesia would be excluded from the study.
研究组 & 干预措施
1
Saline with same volume added to tramadol infusion combined with morphine PCA.
干预措施: 0.9% Saline (Other)
2
Dexamethasone 10mg in 2mL added to tramadol infusion adjunct to morphine PCA.
干预措施: Dexamethasone Sodium Phosphate Injection (Drug)
结局指标
主要结局
Visual analog scale (VAS) of pain
时间窗: 0-48h after surgeries
次要结局
- First requirement of morphine; Total morphine consumption; VAS sedation; VAS satisfaction; Side effects; Overall conditions of patients;(0-48h after surgeries)
